Literature DB >> 9557661

Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus.

Z Li1, T Sergel, E Razvi, T Morrison.   

Abstract

The effects of Newcastle disease virus (NDV) fusion (F) glycoprotein cleavage mutants on the cleavage and syncytium-forming activity of the wild-type F protein were examined. F protein cleavage mutants were made by altering amino acids in the furin recognition region (amino acids 112 to 116) in the F protein of a virulent strain of NDV. Four mutants were made: Q114P replaced the glutamine residue with proline; K115G replaced lysine with glycine; double mutant K115G, R113G replaced both a lysine and an arginine with glycine residues; and a triple mutant, R112G, K115G, F117L, replaced three amino acids to mimic the sequence found in avirulent strains of NDV. All mutants except Q114P were cleavage negative and fusion negative. However, addition of exogenous trypsin cleaved all mutant F proteins and activated fusion. As expected for an oligomeric protein, the fusion-negative mutants had a dominant negative phenotype: cotransfection of wild-type and mutant F protein cDNAs resulted in an inhibition of syncytium formation. The presence of the mutant F protein did not inhibit cleavage of the wild-type protein. Furthermore, evidence is presented that suggests that the mutant protein and the wild-type protein formed heterooligomers. By measuring the syncytium-forming activity of the wild-type protein at various ratios of expression of mutant and wild-type protein, results were obtained that are most consistent with the notion that the size of the functionally active NDV F protein in these assays is a single oligomer, likely a trimer. That a larger oligomer, containing a mix of both wild-type and mutant F proteins, has partial activity cannot, however, be ruled out.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557661      PMCID: PMC109601          DOI: 10.1128/JVI.72.5.3789-3795.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

2.  Lipofection reagents prepared by a simple ethanol injection technique.

Authors:  M J Campbell
Journal:  Biotechniques       Date:  1995-06       Impact factor: 1.993

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Mutations in the cytoplasmic domain of the fusion glycoprotein of Newcastle disease virus depress syncytia formation.

Authors:  T Sergel; T G Morrison
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

5.  Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage.

Authors:  Y Nagai; H D Klenk
Journal:  Virology       Date:  1977-03       Impact factor: 3.616

6.  The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer.

Authors:  T Sakaguchi; Q Tu; L H Pinto; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

7.  Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus.

Authors:  S Bagai; R A Lamb
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus.

Authors:  L W McGinnes; T G Morrison
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

9.  Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein.

Authors:  J N Reitter; T Sergel; T G Morrison
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers.

Authors:  T Danieli; S L Pelletier; Y I Henis; J M White
Journal:  J Cell Biol       Date:  1996-05       Impact factor: 10.539

View more
  20 in total

1.  Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.

Authors:  T A Sergel; L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Requirements for the assembly and release of Newcastle disease virus-like particles.

Authors:  Homer D Pantua; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Glycosylation modulates arenavirus glycoprotein expression and function.

Authors:  Cyrille J Bonhomme; Althea A Capul; Elvin J Lauron; Lydia H Bederka; Kristeene A Knopp; Michael J Buchmeier
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

5.  Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein.

Authors:  Kelly Ann Meulendyke; Mark Allen Wurth; Richard O McCann; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 6.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

7.  Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes.

Authors:  L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

8.  Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.

Authors:  J K Young; D Li; M C Abramowitz; T G Morrison
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

9.  Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces.

Authors:  Lori W McGinnes; Kathryn Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  Mutational analysis of heptad repeats in the membrane-proximal region of Newcastle disease virus HN protein.

Authors:  J Stone-Hulslander; T G Morrison
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.